Memantine Hydrochloride Tablet
Product Images NDC 0591-3875

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 0591-3875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine Hydrochloride Tablets 01

FDA Label Image

Memantine Hydrochloride Tablets 02

The text describes a figure showing the time course of change from baseline in ADCS-ADL score for patients who completed 28 weeks of treatment. There is information in the figure about the mean change from baseline and standard error of the mean.*

FDA Label Image

Memantine Hydrochloride Tablets 03

The text seems to be a figure caption describing a graph. It shows the cumulative percentage of patients completing 28 weeks of double-blind treatment with specified changes from baseline in ADCS-ADL scores. It does not provide any further information.*

FDA Label Image

Memantine Hydrochloride Tablets 04

FDA Label Image

Memantine Hydrochloride Tablets 05

The figure 4 shows the cumulative percentage of patients who completed 28 weeks of double-blind treatment with specified changes from baseline in SIB scores. No further information is available to generate a more specific description.*

FDA Label Image

Memantine Hydrochloride Tablets 06

The figure shows the time course of the change from baseline in ADCS-ADL score for patients who completed 24 weeks of treatment. The text also includes some headings and labels related to the chart, such as "Moan (+ SEM) Change from Baseline" and "Weeks of Treatment," but there is not enough context to provide a full description of the study or its results.*

FDA Label Image

Memantine Hydrochloride Tablets 07

FDA Label Image

Memantine Hydrochloride Tablets 08

This is a graph (Figure 7) that shows the time course of the change from baseline in SIB score (a measure of cognitive function) for patients who completed 24 weeks of treatment. There is not much context or additional information but it seems to be related to a clinical trial.*

FDA Label Image

Memantine Hydrochloride Tablets 09

This text describes a figure labeled as "Figure 8" which shows the cumulative percentage of patients who completed 24 weeks of double-blind treatment and the specified changes from the baseline in SIB scores. It is not possible to provide specific details about the changes or treatment as the text only provides a brief context.*

FDA Label Image

Memantine Hydrochloride Tablets 0a

Memantine HCI is a medication available in a pack of 60 tablets with each tablet containing a significant amount of Memantine Hydrochloride. Actavis is the brand that has manufactured this medication, and it is only available on prescription. It is recommended that patients follow the directions provided on the package insert for the proper dosage. It is very important to keep the medication away from children and store at room temperature (between 20-25°C). Moz Phama CrH & KGaA is the licensing company while Actavis maintains a facility for manufacturing and distribution in the USA.*

FDA Label Image

Memantine Hydrochloride Tablets 0b

FDA Label Image

Memantine Hydrochloride Tablets 0c

This is a description of Memantine Hydrochloride tablets, with NDC number 0591-3875-60, manufactured by Actavis. Each tablet contains memantine, with usual dosage indicated on the packaging and prescribing information. The drug should be kept out of reach of children and stored at controlled room temperature. The tablets are licensed from Merz Pharma Gmbé & o.KGak and distributed by Retaus Parm, Inc. in Parsippany, USA.*

FDA Label Image

Memantine Hydrochloride Tablets 0d

FDA Label Image

Memantine Hydrochloride Tablets 0e

The provided text is not readable.*

FDA Label Image

Memantine Hydrochloride Tablets 0f

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.